Key result
The cardiovascular health clinical decision support tools were highly acceptable, with 94% of breast cancer survivors liking the tool and 85% of oncology providers reporting they would use it.
Why the study?
Many breast cancer survivors are more likely to die from cardiovascular disease than cancer, making cardiovascular health an increasing concern.
Does an EHR-enabled cardiovascular health tool improve awareness of cardiovascular risk factors and demonstrate usability among breast cancer survivors and oncology providers?
Cross-Sectional (n=69)
No
Does an EHR-enabled cardiovascular health tool improve awareness of cardiovascular risk factors and demonstrate usability among breast cancer survivors and oncology providers?
An EHR-enabled cardiovascular health assessment tool is highly acceptable and usable for both breast cancer survivors and oncology providers, significantly improving patient awareness of cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
May support EHR tools to raise CV risk awareness in survivors; leaves open impact on outcomes in prospective trials.
Weaver et al. (2020) conducted a cross-sectional in Breast cancer (n=69). Cardiovascular health assessment tools (AH-HA and Vigor-Us) was evaluated on Usability and acceptability of the cardiovascular health tool. The cardiovascular health clinical decision support tools were highly acceptable, with 94% of breast cancer survivors liking the tool and 85% of oncology providers reporting they would use it.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: